OFAC sanctions Chinese chemical company and related parties in synthetic drug crackdown

This article is machine translated
Show original

*This article has been automatically translated. Please refer to the original article for accurate content.

summary

OFAC sanctioned China-based chemical company Guangzhou Tengyue Chemical Co., Ltd. and two individuals for smuggling synthetic opioids and cutting agents into the United States.
The sanctions include Bitcoin addresses associated with Guangzhou Tengyue official Huang Xiaojun, who coordinated shipments of illegal drugs to the United States.
This action is part of a joint effort with the DEA and FBI to combat the trafficking of synthetic drugs and dangerous painkilling chemicals, often used as cutting agents.

Today, the U.S. Department of the Treasury's Office of Foreign Assets Control (OFAC), in coordination with the U.S. Drug Enforcement Administration (DEA) and the Federal Bureau of Investigation (FBI), sanctioned China-based chemical company Guangzhou Tengyue Chemical Co., Ltd. (Guangzhou Tengyue) and two of its associates for smuggling synthetic opioids . Sanctions also apply to the cryptocurrency address of Chinese national Huang Xiaojun, who attempted to sell controlled substances to U.S. buyers on behalf of Guangzhou Tengyue in 2023.

According to OFAC, the designated entities trafficked nitazenes, a synthetic substance that can cause respiratory failure and is abused for its opioid-like effects. Guangzhou Tengyue also promoted the sale of xylazine (“tranq”), a veterinary sedative that is a particularly dangerous cutting agent because it is resistant to Narcan (a standard overdose treatment). Despite these risks, Guangzhou Tengyue actively sold these substances, assuring buyers that they would clear U.S. customs.

Guangzhou Tengyue's on-chain activities

Huang Xiaojun's cryptocurrency address was used by Guangzhou Tengyue in an attempt to sell controlled substances to a US buyer in 2023. Payments to this address have also been observed from cryptocurrency ATMs and darknet market vendors, as shown in the investigation tool graph below. Xiaojun's address received $1.26 million from January 2021 to January 2025.

Strategic Implications

"This action demonstrates the U.S. government's continued focus on disrupting the financial infrastructure of international drug trafficking organizations, particularly their cryptocurrency payment channels. By designating specific cryptocurrency addresses, OFAC is providing cryptocurrency businesses with specific operational information to identify and prevent transactions with drug trafficking organizations."

We have labeled the above Bitcoin addresses in our products and will continue to monitor additional addresses and organizations associated with synthetic opioid trafficking.

This website contains links to third-party sites that are not under the control of Chainalysis, Inc. or its affiliates (collectively “Chainalysis”). Access to such information does not imply association with, endorsement of, approval of, or recommendation by Chainalysis of the site or its operators, and Chainalysis is not responsible for the products, services, or other content hosted therein.

This material is for informational purposes only, and is not intended to provide legal, tax, financial, or investment advice. Recipients should consult their own advisors before making these types of decisions. Chainalysis has no responsibility or liability for any decision made or any other acts or omissions in connection with Recipient's use of this material.

Chainalysis does not guarantee or warrant the accuracy, completeness, timeliness, suitability or validity of the information in this report and will not be responsible for any claims attributable to errors, omissions, or other inaccuracies of any part of such material.

The post OFAC sanctions Chinese chemical company and associates in synthetic drug crackdown appeared first on Chainalysis .

Source
Disclaimer: The content above is only the author's opinion which does not represent any position of Followin, and is not intended as, and shall not be understood or construed as, investment advice from Followin.
Like
Add to Favorites
Comments